Abstract
Tyrosine kinases play a prominent role in human cancer, yet the oncogenic signaling pathways driving cell proliferation and survival have been difficult to identify, in part because of the complexity of the pathways and in part because of low cellular levels of tyrosine phosphorylation. In general, global phosphoproteomic approaches reveal small numbers of peptides containing phosphotyrosine. We have developed a strategy that emphasizes the phosphotyrosine component of the phosphoproteome and identifies large numbers of tyrosine phosphorylation sites. Peptides containing phosphotyrosine are isolated directly from protease-digested cellular protein extracts with a phosphotyrosine-specific antibody and are identified by tandem mass spectrometry. Applying this approach to several cell systems, including cancer cell lines, shows it can be used to identify activated protein kinases and their phosphorylated substrates without prior knowledge of the signaling networks that are activated, a first step in profiling normal and oncogenic signaling networks.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
ZNF330/NOA36 interacts with HSPA1 and HSPA8 and modulates cell cycle and proliferation in response to heat shock in HEK293 cells
Biology Direct Open Access 30 May 2023
-
Src: coordinating metabolism in cancer
Oncogene Open Access 10 October 2022
-
Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma
Journal of Experimental & Clinical Cancer Research Open Access 09 March 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout



References
Blume-Jensen, P. & Hunter, T. Oncogenic kinase signalling. Nature 411, 355–365 (2001).
Sawyers, C.L. Rational therapeutic intervention in cancer: kinases as drug targets. Curr. Opin. Genet. Dev. 12, 111–115 (2002).
Mann, M. et al. Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends Biotechnol. 20, 261–268 (2002).
Ficarro, S.B. et al. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat. Biotechnol. 20, 301–305 (2002).
Ficarro, S. et al. Phosphoproteome analysis of capacitated human sperm. Evidence of tyrosine phosphorylation of a kinase-anchoring protein 3 and valosin-containing protein/p97 during capacitation. J. Biol. Chem. 278, 11579–11589 (2003).
Pandey, A. et al. Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors. Proc. Natl. Acad. Sci. USA 97, 179–184 (2000).
Pandey, A. et al. Identification of a novel immunoreceptor tyrosine-based activation motif-containing molecule, STAM2, by mass spectrometry and its involvement in growth factor and cytokine receptor signaling pathways. J. Biol. Chem. 275, 38633–38639 (2000).
Pandey, A. et al. Cloning of a novel phosphotyrosine binding domain containing molecule, Odin, involved in signaling by receptor tyrosine kinases. Oncogene 21, 8029–8036 (2002).
Salomon, A.R. et al. Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. Proc. Natl. Acad. Sci. USA 100, 443–448 (2003).
Brill, L.M. et al. Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry. Anal. Chem. 76, 2763–2772 (2004).
Marcus, K., Immler, D., Sternberger, J. & Meyer, H.E. Identification of platelet proteins separated by two-dimensional gel electrophoresis and analyzed by matrix assisted laser desorption/ionization-time of flight-mass spectrometry and detection of tyrosine-phosphorylated proteins. Electrophoresis 21, 2622–2636 (2000).
Quadroni, M. & James, P. Phosphopeptide analysis. EXS 88, 199–213 (2000).
Schneider, U., Schwenk, H.U. & Bornkamm, G. Characterization of EBV-genome negative “null” and “T” cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int. J. Cancer 19, 621–626 (1977).
Srivastava, A.K. & St-Louis, J. Smooth muscle contractility and protein tyrosine phosphorylation. Mol. Cell. Biochem. 176, 47–51 (1997).
Eng, J.K., McCormack, A.L. & Yates, J.R., III . An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5, 976–989 (1994).
Kane, L.P., Lin, J. & Weiss, A. Signal transduction by the TCR for antigen. Curr. Opin. Immunol. 12, 242–249 (2000).
Calalb, M.B., Polte, T.R. & Hanks, S.K. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol. Cell. Biol. 15, 954–963 (1995).
Belsches, A.P., Haskell, M.D. & Parsons, S.J. Role of c-Src tyrosine kinase in EGF-induced mitogenesis. Front. Biosci. 2, d501–d518 (1997).
Bache, K.G., Raiborg, C., Mehlum, A., Madshus, I.H. & Stenmark, H. Phosphorylation of Hrs downstream of the epidermal growth factor receptor. Eur. J. Biochem. 269, 3881–3887 (2002).
Schaller, M.D. et al. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol. Cell. Biol. 14, 1680–1688 (1994).
Bouton, A.H., Riggins, R.B. & Bruce-Staskal, P.J. Functions of the adapter protein Cas: signal convergence and the determination of cellular responses. Oncogene 20, 6448–6458 (2001).
Curtis, D.J. et al. Adaptor protein SKAP55R is associated with myeloid differentiation and growth arrest. Exp. Hematol. 28, 1250–1259 (2000).
Wang, Y.H., Li, F., Schwartz, J.H., Flint, P.J. & Borkan, S.C. c-Src and HSP72 interact in ATP-depleted renal epithelial cells. Am. J. Physiol. Cell Physiol. 281, C1667–C1675 (2001).
Frame, M.C., Fincham, V.J., Carragher, N.O. & Wyke, J.A. v-Src′s hold over actin and cell adhesions. Nat. Rev. Mol. Cell Biol. 3, 233–245 (2002).
Pulford, K. et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 89, 1394–1404 (1997).
Morris, S.W. et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263, 1281–1284 (1994).
Fujimoto, J. et al. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc. Natl. Acad. Sci. USA 93, 4181–4186 (1996).
MacCoss, M.J. et al. Shotgun identification of protein modifications from protein complexes and lens tissue. Proc. Natl. Acad. Sci. USA 99, 7900–7905 (2002).
Bai, R.Y., Dieter, P., Peschel, C., Morris, S.W. & Duyster, J. Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-γ to mediate its mitogenicity. Mol. Cell. Biol. 18, 6951–6961 (1998).
van der Geer, P., Wiley, S., Gish, G.D. & Pawson, T. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions. Curr. Biol. 6, 1435–1444 (1996).
Zamo, A. et al. Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene 21, 1038–1047 (2002).
Zhang, Q. et al. Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma. J. Immunol. 168, 466–474 (2002).
Khoury, J.D. et al. Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK(+) and ALK(−) anaplastic large cell lymphoma. Clin. Cancer Res. 9, 3692–3699 (2003).
Darnell, J.E. Jr., Kerr, I.M. & Stark, G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415–1421 (1994).
Szebeni, A., Hingorani, K., Negi, S. & Olson, M.O. Role of protein kinase CK2 phosphorylation in the molecular chaperone activity of nucleolar protein b23. J. Biol. Chem. 278, 9107–9115 (2003).
Bischof, D., Pulford, K., Mason, D.Y. & Morris, S.W. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol. Cell. Biol. 17, 2312–2325 (1997).
Carr, S. et al. The need for guidelines in publication of peptide and protein identification data: working group on publication guidelines for peptide and protein identification data. Mol. Cell. Proteomics 3, 531–533 (2004).
Nesvizhskii, A.I., Keller, A., Kolker, E. & Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646–4658 (2003).
Hornbeck, P.V., Chabra, I., Kornhauser, J.M., Skrzypek, E. & Zhang, B. PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics 4, 1551–1561 (2004).
Rappsilber, J., Ishihama, Y. & Mann, M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 75, 663–670 (2003).
Gerber, S.A., Rush, J., Stemman, O., Kirschner, M.W. & Gygi, S.P. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. USA 100, 6940–6945 (2003).
Acknowledgements
We are grateful to Jeffrey Knott, Jason Reynolds and Matthew Prokop for providing synthetic peptides, Sandra Schieferl for the 3T3-Src cell line and David Mason for advice on the use of ALCL cell lines. We thank Ross M. Tomaino, Scott A. Gerber and Steven P. Gygi for helping us collect tandem mass spectra in the early stages of this project, and Daniel Schwartz, Sean A. Beausoleil, Rob Duarte and Steven P. Gygi for producing heat maps for the phosphotyrosine peptides we identified. This work was supported by a Small Business Innovation Research phase I grant 1R43CA101106 of the Innovative Molecular Analysis Technologies program from the National Cancer Institute (J.R.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
The reference library-searching strategy. (PDF 269 kb)
Supplementary Table 1
Phosphotyrosine peptides from signaling proteins found in pervanadate-treated Jurkat cells (PDF 52 kb)
Supplementary Table 2
Phosphotyrosine peptides from Jurkat-pervanadate-trypsin/P-Tyr-100 (PDF 70 kb)
Supplementary Table 3
Phosphotyrosine peptides found in Jurkat-pervanadate-trypsin 15–25% acetonitrile fraction/P-Tyr-100 during reproducibility studies (PDF 55 kb)
Supplementary Table 4
Phosphotyrosine peptides from signaling proteins found in 3T3-Src (PDF 54 kb)
Supplementary Table 5
Phosphotyrosine peptides from 3T3-Src-trypsin/P-Tyr-100 (PDF 70 kb)
Supplementary Table 6
Comparison of non-redundant phosphotyrosine peptides from anaplastic large cell lymphoma cell lines, Karpas 299 or SU-DHL-1-trypsin/P-Tyr-100 (PDF 65 kb)
Supplementary Table 7
Phosphotyrosine peptides from anaplastic large cell lymphoma cell lines, Karpas 299 or SU-DHL-1-trypsin/P-Tyr-100 (PDF 106 kb)
Supplementary Table 8
Phosphotyrosine peptides from SU-DHL-1-trypsin or chymotrypsin or endoproteinase GluC or elastase/P-Tyr-100 (PDF 78 kb)
Supplementary Table 9
Number of above-threshold peptide assignments from forward and reverse databases (PDF 33 kb)
Rights and permissions
About this article
Cite this article
Rush, J., Moritz, A., Lee, K. et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 23, 94–101 (2005). https://doi.org/10.1038/nbt1046
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1046
This article is cited by
-
ZNF330/NOA36 interacts with HSPA1 and HSPA8 and modulates cell cycle and proliferation in response to heat shock in HEK293 cells
Biology Direct (2023)
-
Src: coordinating metabolism in cancer
Oncogene (2022)
-
Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma
Journal of Experimental & Clinical Cancer Research (2021)
-
A non-invasive cancer gene detection technique using FLANN based adaptive filter
Microsystem Technologies (2021)